Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 6/2011

Open Access 01-12-2011 | Research

Effects of probiotics on serum levels of Th1/Th2 cytokine and clinical outcomes in severe traumatic brain-injured patients: a prospective randomized pilot study

Authors: Min Tan, Jing-Ci Zhu, Jiang Du, Li-Mei Zhang, Hua-Hua Yin

Published in: Critical Care | Issue 6/2011

Login to get access

Abstract

Introduction

Traumatic brain injury (TBI) is associated with a profound immunological dysfunction manifested by a severe shift from T-helper type 1 (Th1) to T-helper type 2 (Th2) response. This predisposes patients to infections, sepsis, and adverse outcomes. Probiotic bacteria have been shown to balance the Th1/Th2 cytokines in allergic murine models and patients. For the present study, we hypothesized that the enteral administration of probiotics would adjust the Th1/Th2 imbalance and improve clinical outcomes in TBI patients.

Methods

We designed a prospective, randomized, single-blind study. Patients with severe TBI and Glasgow Coma Scale scores between 5 and 8 were included, resulting in 26 patients in the control group and 26 patients in the probiotic group. All patients received enteral nutrition via a nasogastric tube within 24 to 48 hours following admission. In addition, the probiotic group received 109 bacteria of viable probiotics per day for 21 days. The associated serum levels of Th1/Th2 cytokines, Acute Physiology and Chronic Health Evaluation (APACHE) II and Sequential Organ Failure Assessment (SOFA) scores, nosocomial infections, length of ICU stay, and 28-day mortality rate were studied.

Results

The patients responded to viable probiotics, and showed a significantly higher increase in serum IL-12p70 and IFNγ levels while also experiencing a dramatic decrease in IL-4 and IL-10 concentrations. APACHE II and SOFA scores were not significantly affected by probiotic treatment. Patients in the probiotic group experienced a decreased incidence of nosocomial infections towards the end of the study. Shorter ICU stays were also observed among patients treated with probiotic therapy. However, the 28-day mortality rate was unaffected.

Conclusions

The present study showed that daily prophylactic administration of probiotics could attenuate the deviated Th1/Th2 response induced by severe TBI, and could result in a decreased nosocomial infection rate, especially in the late period.

Trial registration

ChiCTR-TRC-10000835.
Appendix
Available only for authorised users
Literature
1.
2.
Meisel C, Schwab JM, Prass K, Meisel A, Dirnagl U: Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci 2005, 6: 775-786.CrossRefPubMed
3.
Moore KW, O'Garra A, Malefyt RW, Vieira P, Mosmann TR: Interleukin-10. Annu Rev Immunol 1993, 11: 165-190. 10.1146/annurev.iy.11.040193.001121CrossRefPubMed
4.
Woiciechowsky C, Asadullah K, Nestler D, Eberhardt B, Platzer C, Schöning B, Glöckner F, Lanksch WR, Volk HD, Döcke WD: Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med 1998, 4: 808-813. 10.1038/nm0798-808CrossRefPubMed
5.
DiPiro JT, Howdieshell TR, Goddard JK, Callaway DB, Hamilton RG, Mansberger AR: Association of interleukin-4 plasma levels with traumatic injury and clinical course. Arch Surg 1995, 130: 1159-1162. 10.1001/archsurg.1995.01430110017004CrossRefPubMed
6.
Miller AC, Rashid RM, Elamin EM: The 'T' in trauma: the helper T-cell response and the role of immunomodulation in trauma and burn patients. J Trauma 2007, 63: 1407-1417. 10.1097/TA.0b013e31815b839eCrossRefPubMed
7.
Isakow W, Morrow LE, Kollef MH: Probiotics for preventing and treating nosocomial infections: review of current evidence and recommendations. Chest 2007, 132: 286-294. 10.1378/chest.06-2156CrossRefPubMed
8.
Bengmark S, Andersson R, Mangiante G: Uninterrupted perioperative enteral nutrition. Clin Nutr 2001, 20: 11-19. 10.1054/clnu.2000.0111CrossRefPubMed
9.
Wolvers D, Antoine JM, Myllyluoma E, Schrezenmeir J, Szajewska H, Rijkers GT: Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of infections by probiotics. J Nutr 2010, 140: 698S-712S. 10.3945/jn.109.113753CrossRefPubMed
10.
Siempos LL, Ntaidou TK, Falagas ME: Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. Crit Care Med 2010, 38: 954-962. 10.1097/CCM.0b013e3181c8fe4bCrossRefPubMed
11.
Watkinson PJ, Barber VS, Dark P, Young JD: The use of pre-pro-and synbiotics in adult intensive care unit patients: systematic review. Clin Nutr 2007, 26: 182-192. 10.1016/j.clnu.2006.07.010CrossRefPubMed
12.
Schultz MJ, Haas L: Antibiotics or probiotics as preventive measures against ventilator-associated pneumonia: a literature review. Crit Care 2011, 15: R18. 10.1186/cc9963PubMedCentralCrossRefPubMed
13.
Kotzampassi K, Giamarellos-Bourboulis EJ, Voudouris A, Kazamias P, Eleftheriadis E: Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically ill trauma patients: early results of a randomized controlled trial. World J Surg 2006, 30: 1848-1855. 10.1007/s00268-005-0653-1CrossRefPubMed
14.
15.
Artis D: Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 2008, 8: 411-420. 10.1038/nri2316CrossRefPubMed
16.
Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 1985, 13: 818-829. 10.1097/00003246-198510000-00009CrossRefPubMed
17.
Kajdacsy-Balla Amaral AC, Andrade FM, Moreno R, Artigas A, Cantraine F, Vincent JL: Use of the sequential organ failure assessment score as a severity score. Intensive Care Med 2005, 31: 243-249. 10.1007/s00134-004-2528-6CrossRefPubMed
18.
Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections. Am J Infect Control 1988, 16: 128-140. 10.1016/0196-6553(88)90053-3CrossRefPubMed
19.
American Thoracic Society Infectious Diseases Society of America: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171: 388-416.CrossRef
20.
Alberda C, Gramlich L, Meddings J, Field C, McCargar L, Kutsogiannis D, Fedorak R, Madsen K: Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 2007, 85: 816-823.PubMed
21.
Giamarellos-Bourboulis EJ, Bengmark S, Kanellakopoulou K, Kotzampassi K: Pro-and synbiotics to control inflammation and infection in patients with multiple injuries. J Trauma 2009, 67: 815-821. 10.1097/TA.0b013e31819d979eCrossRefPubMed
22.
McNaught CE, Woodcock NP, Anderson AD, MacFie J: A prospective randomised trial of probiotics in critically ill patients. Clin Nutr 2005, 24: 211-219. 10.1016/j.clnu.2004.08.008CrossRefPubMed
23.
Spindler-Vesel A, Bengmark S, Vovk I, Cerovic O, Kompan L: Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients. JPEN J Parenter Enteral Nutr 2007, 31: 119-126. 10.1177/0148607107031002119CrossRefPubMed
24.
Ghadimi D, Fölster-Holst R, de Vrese M, Winkler P, Heller KJ, Schrezenmeir J: Effects of probiotic bacteria and their genomic DNA on Th1/Th2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects. Immunobiology 2008, 213: 677-692. 10.1016/j.imbio.2008.02.001CrossRefPubMed
25.
Schiavi E, Barletta B, Butteroni C, Corinti S, Boirivant M, Di Felice G: Oral therapeutic administration of a probiotic mixture suppresses established Th2 responses and systemic anaphylaxis in a murine model of food allergy. Allergy 2011, 66: 499-508. 10.1111/j.1398-9995.2010.02501.xCrossRefPubMed
26.
Takahashi N, Kitazawa H, Iwabuchi N, Xiao JZ, Miyaji K, Iwatsuki K, Saito T: Oral administration of an immunostimulatory DNA sequence from Bifidobacterium longum improves Th1/Th2 balance in a murine model. Biosci Biotechnol Biochem 2006, 70: 2013-2017. 10.1271/bbb.60260CrossRefPubMed
27.
Sudo N, Yu XN, Aiba Y, Oyama N, Sonoda J, Koga Y, Kubo C: An oral introduction of intestinal bacteria prevents the development of a long-term Th2-skewed immunological memory induced by neonatal antibiotic treatment in mice. Clin Exp Allergy 2002, 32: 1112-1116. 10.1046/j.1365-2222.2002.01430.xCrossRefPubMed
28.
Kapsenberg ML: Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 2003, 3: 984-993. 10.1038/nri1246CrossRefPubMed
29.
Mohamadzadeh M, Olson S, Kalina WV, Ruthel G, Demmin GL, Warfield KL, Bavari S, Klaenhammer TR: Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci USA 2005, 102: 2880-2885. 10.1073/pnas.0500098102PubMedCentralCrossRefPubMed
30.
Christensen HR, Frøkiær H, Pestka JJ: Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunology 2002, 168: 171-178.CrossRef
31.
Hart AL, Lammers K, Brigidi P, Vitali B, Rizzello F, Gionchetti P, Campieri M, Kamm MA, Knight SC, Stagg AJ: Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 2004, 53: 1602-1609. 10.1136/gut.2003.037325PubMedCentralCrossRefPubMed
32.
Morrow LE, Kollef MH, Casale TB: Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. Am J Respir Crit Care Med 2010, 182: 1058-1064. 10.1164/rccm.200912-1853OCPubMedCentralCrossRefPubMed
33.
Barraud D, Blard C, Hein F, Mar on O, Cravoisy A, Nace L, Alla F, Bollaert PE, Gibot S: Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial. Intensive Care Med 2010, 36: 1540-1547. 10.1007/s00134-010-1927-0CrossRefPubMed
34.
Knight DJW, Gardiner D, Banks A, Snape SE, Weston VC, Bengmark S, Girling KJ: Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: a randomised, double-blind, placebo-controlled trial. Intensive Care Med 2009, 35: 854-861. 10.1007/s00134-008-1368-1CrossRefPubMed
35.
Fukushima Y, Miyaguchi S, Yamano T, Kaburagi T, Iino H, Ushida K, Sato K: Improvement of nutritional status and incidence of infection in hospitalised, enterally fed elderly by feeding of fermented milk containing probiotic Lactobacillus johnsonii La1 (NCC533). Br J Nutr 2007, 98: 969-977.CrossRefPubMed
36.
Nylén ES, Alarifi AA: Humoral markers of severity and prognosis of critical illness. Best Pract Res Clin Endoc Met 2001, 15: 553-573. 10.1053/beem.2001.0169CrossRef
37.
Besselink MGH, van Santvoort HC, Buskens E, Boermeester MA, van Goor H, Timmerman HM, Nieuwenhuijs VB, Bollen TL, van Ramshorst B, Witteman BJM: Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008, 371: 651-659. 10.1016/S0140-6736(08)60207-XCrossRefPubMed
38.
Whelan K, Myers CE: Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomized controlled trials, and nonrandomized trials. Am J Clin Nutr 2010, 91: 687-703. 10.3945/ajcn.2009.28759CrossRefPubMed
39.
Delgado S, O'Sullivan E, Fitzgerald G, Mayo B: In vitro evaluation of the probiotic properties of human intestinal Bifidobacterium species and selection of new probiotic candidates. J Appl Microbiol 2008, 104: 1119-1127. 10.1111/j.1365-2672.2007.03642.xCrossRefPubMed
40.
Husebye E, Hellstrom PM, Sundler F, Chen J, Midtvedt T: Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am J Physiol Gastrointest Liver Physiol 2001, 280: G368-G380.PubMed
41.
Camargo L, De Marco F, Barbas C, Hoelz C, Bueno M, Rodrigues M Jr, Amado V, Caserta R, Martino M, Pasternak J: Ventilator associated pneumonia: comparison between quantitative and qualitative cultures of tracheal aspirates. Crit Care 2004, 8: R422-R430. 10.1186/cc2965PubMedCentralCrossRefPubMed
Metadata
Title
Effects of probiotics on serum levels of Th1/Th2 cytokine and clinical outcomes in severe traumatic brain-injured patients: a prospective randomized pilot study
Authors
Min Tan
Jing-Ci Zhu
Jiang Du
Li-Mei Zhang
Hua-Hua Yin
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Critical Care / Issue 6/2011
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc10579

Other articles of this Issue 6/2011

Critical Care 6/2011 Go to the issue

Research

Vitamin D deficiency is associated with mortality in the medical intensive care unit

Commentary

High-frequency oscillatory ventilation and pediatric cardiac surgery: Yes, we can!

Research

Arterial cerebrovascular complications in 94 adults with acute bacterial meningitis

Research

Short women with severe sepsis-related acute lung injury receive lung protective ventilation less frequently: an observational cohort study

Letter

Severity of community-acquired pneumonia treated with low-dose adjunctive corticosteroid

Commentary

The good and the bad of diabetes mellitus in the critically ill